سعر زيفيكام Zeficam‏ 8مجم/2مل فيال للحقن عضل/وريد 2026

Zeficam 8 mg/2 ml vial for intramuscular or intravenous injection containing lornoxicam, an oxicam NSAID, by Eva Pharma, Egypt.

• Common: mild transient headache and dizziness; gastrointestinal effects (nausea, dyspepsia, abdominal pain, diarrhoea, vomiting) are the most commonly observed NSAID adverse events.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Contraindicated in hypersensitivity to lornoxicam or other NSAIDs including acetylsalicylic acid (asthma, rhinitis, angioedema, urticaria), thrombocytopenia, severe heart failure, GI or cerebrovascular bleeding or other bleeding disorders, history of NSAID-related GI bleeding/perforation, active or recurrent peptic ulcer, severe hepatic or renal impairment, and the third trimester of pregnancy.International label, same formulation · Health Products Regulatory Authority (HPRA)

• GI bleeding, ulceration and perforation can occur at any time; use the lowest effective dose for the shortest duration; avoid concomitant NSAIDs including COX-2 inhibitors; monitor renal and hepatic function in at-risk and elderly patients.International label, same formulation · Health Products Regulatory Authority (HPRA)

• Other NSAIDs including COX-2 selective inhibitorsConcomitant use should be avoided.Health Products Regulatory Authority (HPRA)

• Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.International label, same formulation · Health Products Regulatory Authority (HPRA)

English text not available for this section.